Yuqing Tang

Yuqing Tang

Auto-generated profile, based on publicly available information

Yuqing Tang

School of Medicine and Health Management, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 April 2018 in PharmacoEconomics
Verified
Journal Article
Open access
PDF file
YTYuqing Tang
Yuqing Tang
Chaojie LiuChaojie Liu
Chaojie Liu
JLJunjie Liu
Junjie Liu
XZXinping Zhang
Xinping Zhang
KZKeyuan Zuo
Keyuan Zuo
Background The overuse of antibiotics has become a major public health challenge worldwide, especially in low- and middle-income countries, including China. In 2009, the Chinese government launched a series of measures to de-incentivise over-prescription in public health facilities, including decoupling the link between facility income and the sale of medicines. Objectives We evaluated the effects of these measures on procurement costs and the volume of antibiotics in county public hospitals. Methods The study was undertaken in the Hubei province of China, where 64 county public hospitals implemented the reform in sequence at three different stages. A quasi-natural experiment design was employed. We performed generalised linear regressions with a difference-in-differences approach using 22,713 procurement records of antibiotics from November 2014 to December 2016. Results The regression results showed that the reform contributed to a 14.79% increase in total costs for antibiotics (p = 0.013), particularly costs for injectable antibiotics (p = 0.022) and first-line antibiotics (p = 0.030). The procurement prices for antibiotics remained largely comparable to those in the control group, but the reform led to a 17.30% increase in the procurement volume (expressed as defined daily doses) of second-line antibiotics (p = 0.032). Conclusions County public hospitals procured more antibiotics and greater numbers of expensive antibiotics, such as those administered via injection, to compensate for the loss of income from the sale of medicines, leading to an increased total cost of antibiotics.

20 December 2022 in Frontiers in Public Health
Verified
Journal Article
Open access
TXTianqin Xue
Tianqin Xue
Chaojie LiuChaojie Liu
Chaojie Liu
ZLZhuoxian Li
Zhuoxian Li
JLJunjie Liu
Junjie Liu
YTYuqing Tang
Yuqing Tang
Objectives: This study aimed to determine how primary care physicians weigh intervenable patient attributes in their decisions of antibiotic prescribing for upper respiratory tract infections (URTIs).Methods: A discrete choice experiment (DCE) was conducted on 386 primary care physicians selected through a stratified cluster sampling strategy in Hubei province, China. The patient attributes tested in the DCE were identified through semi-structured interviews with 13 primary care physicians, while the choice scenarios were determined by a D-efficient design with a zero prior parameter value. Conditional logit models (CL) and mixed logit models (MXL) were established to determine the preference of the study participants in antibiotic prescribing for URTI patients with various attributes. Relative importance (RI) was calculated to reflect the influence of each attribute.Results: In addition to age and duration of symptoms, the interventionable patient attributes were also considered by the primary care physicians in their antibiotic prescribing decisions. They preferred to prescribe antibiotics for URTI patients with difficulties to schedule a follow-up appointment (p < 0.001) and for those without a clear indication of refusal to antibiotics (p < 0.001). Patient request for antibiotics had an RI ranging from 15.2 to 16.3%, compared with 5.1–5.4% for easiness of follow-up appointment. The influence of these two interventionable patient attributes was most profound in the antibiotic prescribing decisions for patients aged between 60 and 75 years as indicated by their interaction effects with age (β = 0.69 for request for antibiotics, p < 0.01; β = −1.2 for easiness of follow-up, p < 0.001).Conclusion: Reducing patient pressure and improving accessibility and continuity of care may help primary care physicians make rational antibiotic prescribing decisions for URTIs.

1 October 2019 in The Lancet
Verified
Journal Article
Open access
PDF file
XWXuemei Wang
Xuemei Wang
YTYuqing Tang
Yuqing Tang
CLChenxi Liu
Chenxi Liu
JLJunjie Liu
Junjie Liu
YCYouwen Cui
Youwen Cui
XZXinping Zhang
Xinping Zhang
Background The overuse of antibiotics is a major public health problem worldwide, especially in low-income and middle-income countries. However, there are few polices specific to antibiotic stewardship in primary care, and their effectiveness is unclear. A restrictive-prescribing stewardship policy was introduced in Hubei province, China, in November, 2014. We aimed to evaluate the effects of this policy on antibiotic consumption in primary care in the region. Methods Monthly antibiotic consumption data were extracted from the Hubei Medical Procurement Administrative Agency system from Sept 1, 2012, to Aug 31, 2017. An interrupted time-series analysis combined with Anatomical Therapeutic Chemical/Defined Daily Dose methodology and European Surveillance of Antimicrobial Consumption Quality Indictors was performed to evaluate the effects of the restrictive-prescribing stewardship policy on antibiotic consumption in primary care. The Durbin-Watson test was used to check for autocorrelation, and p values and coefficients were estimated by use of the generalised least squares method. Findings Over the entire study period, a significant reduction (–32·58%, p<0·001) was observed in total antibiotic consumption, which occurred within 1 month after introduction of restrictive prescribing (r=–2·4518, p=0·005) and continued to 2017 (r=–0·1193, p=0·017). Specifically, the use of penicillins (r=–0·0553, p=0·035), cephalosporins (r=–0·0294, p=0·037), and macrolides/lincosamides/streptogramins (r=–0·0182, p=0·003) decreased from before to after the intervention. The restrictive intervention was also associated with an immediate decline in the contribution of β-lactamase-sensitive penicillins to total antibiotic use (r=–2·9126, p=0·001) and a decline from baseline in the use of oral antibiotics (r=–0·0815, p=0·018). However, an immediate increase in the contribution of third-generation and fourth-generation cephalosporins to total antibiotic use (r=5·0352, p=0·005) and an increase from baseline in the contribution of fluoroquinolones to total antibiotic use (r=0·0406, p=0·037) were observed after the intervention. Finally, restrictive prescribing was associated with an immediate increase in the ratio of broad-spectrum to narrow-spectrum antibiotic use (r=1·8747, p=0·001), although use of both types of antibiotics significantly declined from before to after the intervention (broad-spectrum antibiotics: r=–0·0423, p=0·017; narrow-spectrum antibiotics: r=–0·0223, p=0·006). Interpretation Restrictive antibiotic prescribing in primary care in China was effective in reducing total antibiotic consumption, especially use of penicillins, cephalosporins, and macrolides/lincosamides/streptogramins. However, the effects of the intervention on some other antibiotics were mixed. Stronger administrative regulation focusing on specific antibiotics, such as third-generation and fourth-generation cephalosporins, fluoroquinolones, and broad-spectrum antibiotics, is needed in the future. Funding National Natural Science Foundation of China Youth Fund (grant number 71704058 ).